Literature DB >> 8912552

Epidemiology of Kaposi's sarcoma in the Nordic countries before the AIDS epidemic.

H Hjalgrim1, M Melbye, E Pukkala, F Langmark, M Frisch, M Dictor, A Ekbom.   

Abstract

Based on data from the Nordic cancer registries, time-related trends in incidence of Kaposi's sarcoma (KS) were analysed in four ethnically similar populations before the AIDS epidemic. Data were available for different time periods in Denmark (1970-79), Sweden (1958-79), Finland (1953-79) and Norway (1953-79). KS was more common among men than among women aged 60 years or more, whereas no differences were observed for younger persons. The incidence of KS differed significantly between the four countries (P = 0.0001); Sweden having the highest and Denmark the lowest rates. Similarly, regional differences in incidence were observed within Sweden, rates being higher in the northern than in the southern areas (Ptrend = 0.002). Overall, in Nordic men the world standardised incidence rose from 0.5/1,000,000 person-years in the period 1953-57 to 1.8/1,000,000 person-years in 1978-79; in Nordic women, the corresponding rates were 0.2/1,000,000 person-years and 0.8/1,000,000 person-years respectively. The rate of increase was similar in Sweden, Finland and Norway (P = 0.14), whereas the short period of observation in Denmark precluded precise assessment of time-related incidence trends. These observations cannot be explained by registrational procedures or known risk factors for KS, and argue that environmental factors play an important role in the development of the disease.

Entities:  

Mesh:

Year:  1996        PMID: 8912552      PMCID: PMC2074794          DOI: 10.1038/bjc.1996.572

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

1.  Risk of Kaposi's sarcoma and sexual practices associated with faecal contact in homosexual or bisexual men with AIDS.

Authors:  V Beral; D Bull; S Darby; I Weller; C Carne; M Beecham; H Jaffe
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

2.  Epidemiology of Kaposi's sarcoma in Sweden prior to the acquired immunodeficiency syndrome.

Authors:  M Dictor; R Attewell
Journal:  Int J Cancer       Date:  1988-09-15       Impact factor: 7.396

3.  Kaposi's sarcoma in the Swiss Canton of Vaud, 1974-1990.

Authors:  F Levi; S Franceschi; C La Vecchia
Journal:  Eur J Cancer       Date:  1993       Impact factor: 9.162

4.  Kaposi's sarcoma in Sardinia: an epidemiologic and genetic investigation.

Authors:  D Cerimele; L Contu; S Scappaticci; F Cottoni
Journal:  Ann N Y Acad Sci       Date:  1984       Impact factor: 5.691

5.  [Kaposi's sarcoma. Development in Norway during the period 1957-86].

Authors:  S Harvei; F Langmark; T Haldorsen
Journal:  Tidsskr Nor Laegeforen       Date:  1990-05-10

6.  Incidence of Kaposi's sarcoma and mycosis fungoides in the United States including Puerto Rico, 1973-81.

Authors:  R J Biggar; J Horm; J F Fraumeni; M H Greene; J J Goedert
Journal:  J Natl Cancer Inst       Date:  1984-07       Impact factor: 13.506

7.  Kaposi's sarcoma: retrospective study of 67 cases with the classical form.

Authors:  R Friedman-Birnbaum; S Weltfriend; I Katz
Journal:  Dermatologica       Date:  1990

8.  Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection?

Authors:  V Beral; T A Peterman; R L Berkelman; H W Jaffe
Journal:  Lancet       Date:  1990-01-20       Impact factor: 79.321

9.  Kaposi's sarcoma in England and Wales before the AIDS epidemic.

Authors:  A E Grulich; V Beral; A J Swerdlow
Journal:  Br J Cancer       Date:  1992-12       Impact factor: 7.640

10.  Kaposi's sarcoma in Italy before and after the AIDS epidemic.

Authors:  M Geddes; S Franceschi; A Barchielli; F Falcini; S Carli; G Cocconi; E Conti; P Crosignani; L Gafà; L Giarelli
Journal:  Br J Cancer       Date:  1994-02       Impact factor: 7.640

View more
  8 in total

Review 1.  KSHV and the pathogenesis of Kaposi sarcoma: listening to human biology and medicine.

Authors:  Don Ganem
Journal:  J Clin Invest       Date:  2010-04-01       Impact factor: 14.808

2.  High incidence of classical Kaposi's sarcoma in Iceland and the Faroe Islands.

Authors:  H Hjalgrim; H Tulinius; J Dalberg; S Hardarson; M Frisch; M Melbye
Journal:  Br J Cancer       Date:  1998-04       Impact factor: 7.640

3.  Incidence of Kaposi Sarcoma in Sweden is Decreasing.

Authors:  Giedre Bieliauskiene; Oscar Zaar; Isabel Kolmodin; Martin Gillstedt; John Paoli
Journal:  Acta Derm Venereol       Date:  2020-10-28       Impact factor: 3.875

4.  Oncogenic Virus Infections in the General Population and End-stage Renal Disease Patients With Special Emphasis on Kaposi's Sarcoma Associated Herpes Virus (KSHV) in Northeast of Iran.

Authors:  Sanaz Ahmadi Ghezeldasht; Tahereh Hassannia; Houshang Rafatpanah; Reza Hekmat; Narges Valizadeh; Majid Ghayour Mobarhan; Seyed Abdolrahim Rezaee
Journal:  Jundishapur J Microbiol       Date:  2015-03-21       Impact factor: 0.747

5.  Incidence rates of classical Kaposi's sarcoma and multiple myeloma do not correlate.

Authors:  H Hjalgrim; M Frisch; M Melbye
Journal:  Br J Cancer       Date:  1998-08       Impact factor: 7.640

6.  Epidemiology of classic Kaposi's sarcoma in the Israeli Jewish population between 1960 and 1998.

Authors:  E Guttman-Yassky; M Bar-Chana; A Yukelson; S Linn; R Friedman-Birnbaum; R Bergman; R Sarid; M Silbermann
Journal:  Br J Cancer       Date:  2003-11-03       Impact factor: 7.640

Review 7.  Review of the distribution of Kaposi's sarcoma-associated herpesvirus (KSHV) in Africa in relation to the incidence of Kaposi's sarcoma.

Authors:  M Dedicoat; R Newton
Journal:  Br J Cancer       Date:  2003-01-13       Impact factor: 7.640

8.  Candidate Predisposition Variants in Kaposi Sarcoma as Detected by Whole-Genome Sequencing.

Authors:  Sanni J Rinne; Lauri J Sipilä; Päivi Sulo; Emmanuelle Jouanguy; Vivien Béziat; Laurent Abel; Jean-Laurent Casanova; Nima Parvaneh; Kamran Balighi; Emma Guttman-Yassky; Ronit Sarid; Lauri A Aaltonen; Mervi Aavikko
Journal:  Open Forum Infect Dis       Date:  2019-07-17       Impact factor: 3.835

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.